| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010377 |
| Receipt No. | R000010891 |
| Scientific Title | Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins |
| Date of disclosure of the study information | 2013/04/15 |
| Last modified on | 2021/04/07 (Ver. 2) |
| Basic information | ||
| Public title | Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins | |
| Acronym | Effect of jizusoippo for Yusho | |
| Scientific Title | Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins | |
| Scientific Title:Acronym | Effect of jizusoippo for Yusho | |
| Region |
|
|
| Condition | |||
| Condition | Yusho disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the effectiveness of Jizusoippo on the symptoms of Yusho. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | respiratory, skin, and neurological symptoms, general fatigue, and QOL |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients take 2.5g of Jizusoippo three times a day after each meal for 6months. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients aged 20 years or older who fulfilled the diagnostic criteria for Yusho established by the National Study Group for the Therapy of Yusho and give their written informed consents are eligible. | |||
| Key exclusion criteria | Patients are not eligible if they have serious diseases (malignant neoplasms, hepatic disorders, renal disorders, or blood disorders), have been treated with any other Kampo formulae, or are women with pregnancy or nursing women. Patients who are judged to have an ineligible health condition by medical doctors are excluded. | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kyushu University Hospital | ||||||
| Division name | Dermatology | ||||||
| Zip code | |||||||
| Address | 3-1-1, Maidashi, Higashiku, Fukuoka | ||||||
| TEL | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyushu University Hospital | ||||||
| Division name | Research and Clinical Center for Yusho | ||||||
| Zip code | |||||||
| Address | 3-1-1, Maidashi, Higashiku, Fukuoka | ||||||
| TEL | 092-642-5211 | ||||||
| Homepage URL | |||||||
| Sponsor | |
| Institute | Kyushu University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010891 |